U.S. Physical Therapy (NYSE:USPH - Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, November 5th. Analysts expect U.S. Physical Therapy to post earnings of $0.68 per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The company had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. During the same quarter last year, the business earned $0.76 EPS. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
U.S. Physical Therapy Trading Down 0.2 %
NYSE USPH traded down $0.20 on Tuesday, hitting $81.48. 90,034 shares of the stock were exchanged, compared to its average volume of 88,955. The company's 50-day moving average price is $83.10 and its two-hundred day moving average price is $92.25. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of 66.27, a P/E/G ratio of 3.83 and a beta of 1.39.
U.S. Physical Therapy Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.16%. U.S. Physical Therapy's payout ratio is presently 143.09%.
Insider Buying and Selling
In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin bought 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares of the company's stock, valued at $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares of the company's stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares in the company, valued at $1,627,445.36. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several analysts recently commented on USPH shares. Barrington Research restated an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, October 9th. StockNews.com raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. Finally, Bank of America reaffirmed a "neutral" rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.
Check Out Our Latest Stock Analysis on U.S. Physical Therapy
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Stories
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.